These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32552069)

  • 41. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
    Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
    AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience.
    Liang P; Wang Y; Zhang D; Yu X; Gao Y; Ni X
    J Urol; 2008 Sep; 180(3):844-8; discussion 848. PubMed ID: 18635230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
    Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
    Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cone-Beam CT-Assisted Ablation of Renal Tumors: Preliminary Results.
    Monfardini L; Gennaro N; Della Vigna P; Bonomo G; Varano G; Maiettini D; Bonello L; Solbiati L; Orsi F; Mauri G
    Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1718-1725. PubMed ID: 31367773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney.
    Meng H; Yang H; Jia H; Pan F; Dong X; Liu B; Li C
    Int J Hyperthermia; 2021; 38(1):691-695. PubMed ID: 33899668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety.
    Guo J; Arellano RS
    J Endourol; 2020 Oct; 34(10):1021-1027. PubMed ID: 32498630
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of General Anesthesia and Conscious Sedation During Computed Tomography-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma.
    Kim HJ; Park BK; Chung IS
    Can Assoc Radiol J; 2018 Feb; 69(1):24-29. PubMed ID: 29198818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.
    Iannuccilli JD; Dupuy DE; Beland MD; Machan JT; Golijanin DJ; Mayo-Smith WW
    Eur Radiol; 2016 Jun; 26(6):1656-64. PubMed ID: 26373755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CT-Guided Microwave Ablation of 45 Renal Tumors: Analysis of Procedure Complexity Utilizing a Percutaneous Renal Ablation Complexity Scoring System.
    Mansilla AV; Bivins EE; Contreras F; Hernandez MA; Kohler N; Pepe JW
    J Vasc Interv Radiol; 2017 Feb; 28(2):222-229. PubMed ID: 27988263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Image-guided radiofrequency ablation of Bosniak category III or IV cystic renal tumors: initial clinical experience.
    Park BK; Kim CK; Lee HM
    Eur Radiol; 2008 Jul; 18(7):1519-25. PubMed ID: 18309492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma.
    Welch BT; Callstrom MR; Morris JM; Kurup AN; Schmit GD; Weisbrod AJ; Lohse CM; Kohli M; Costello BA; Olivier KR; Thompson RH; Boorjian SA; Atwell TD
    J Urol; 2014 Aug; 192(2):357-63. PubMed ID: 24631107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy.
    Goeman L; Joniau S; Oyen R; Van Poppel H
    Urology; 2006 Jan; 67(1):199. PubMed ID: 16413367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-time US/cone-beam CT fusion imaging for percutaneous ablation of small renal tumours: a technical note.
    Monfardini L; Gennaro N; Orsi F; Della Vigna P; Bonomo G; Varano G; Solbiati L; Mauri G
    Eur Radiol; 2021 Oct; 31(10):7523-7528. PubMed ID: 33871707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
    Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
    Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protection from injury to organs adjacent to a renal tumor during Imaging-guided thermal ablation with hydrodissection and pyeloperfusion.
    Adebanjo GAR; Bertolotti L; Iemma E; Martini C; Arrigoni F; Ziglioli F; Maestroni U; De Filippo M
    Eur J Radiol; 2024 Dec; 181():111759. PubMed ID: 39342885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
    Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
    Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of CT-guided percutaneous thermal ablation for hepatocellular carcinoma adjacent to the second porta hepatis.
    Xie L; Cao F; Qi H; Song Z; Shen L; Chen S; Hu Y; Chen C; Fan W
    Int J Hyperthermia; 2019; 36(1):1122-1128. PubMed ID: 31739695
    [No Abstract]   [Full Text] [Related]  

  • 60. Ureteral protection during microwave ablation of renal cell carcinoma: combined use of pyeloperfusion and hydrodissection.
    Samadi K; Arellano RS
    Diagn Interv Radiol; 2018 Nov; 24(6):388-391. PubMed ID: 30406764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.